An STK11 mutation reduces thecapacity of tumor cells to spark off AMP kinase, resulting in a higher power strain [119].Moreover, STK11 has an unfavorable impact on the mTOR cascade, which may result in aberrant mTOR signaling. The gene discussed is MTOR; the disease is neoplasm.